5 Pharmaceutical preparations for the treatment of non-insulin dependent diabetes mellitus (type 2), impaired glucose tolerance, glucosuria, and disturbances of signal action at the cells of the islets of Langerhans and insulin sensitivity in the peripheral tissue in the postprandial phase of mammals, insulin resistance, metabolic acidosis, diabetic neuropathy and nephropathy and of sequelae caused by diabetes mellitus, diabetes mellitus type 1, lipid disorders, hyperlipidemia, metabolism-related hypertension and cardiovascular sequelae caused by hypertension in mammals; pharmaceutical preparations for the treatment of atherosclerosis and its sequelae, inflammatory bowel disease, namely, Crohn's disease and ulcerative colitis, pancreatitis, tumor metastasis, benign prostatic hypertrophy, gingivitis, osteoporosis; pharmaceutical preparations for the prophylaxis or treatment of skin diseases and diseases of the mucosae, autoimmune diseases and inflammatory conditions, and for the prophylaxis or treatment of psychosomatic, neuropsychiatric and depressive illness, and neurodegenerative diseases namely, anxiety, depression, sleep disorders, chronic fatigue, schizophrenia, epilepsy, nutritional disorders, spasm, and chronic pain, multiple sclerosis, Alzheimer's disease; Veterinary preparations for the treatment of metabolic diseases, cancerous diseases, psychosomatic, neuropsychiatric, depressive and neurodegenerative diseases in livestock and domestic animals; All purpose disinfectants, diagnostic reagents for clinical or medical use; Dietary supplements, food for enteral feeding; Agrochemicals, namely fungicides, herbicides and insecticides for agricultural and domestic use
Trademark: 76471856
